SEVEFAST 400 TAB Tablet
NEFROCASA
Top

SEVEFAST 400 TAB Tablet

MRP: 1

Packaging: 10x10

Pack Type: tablet

Composition:

Sevelamer Carbonate 400 mg

Indication:

Used to control serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis. Helps prevent complications of hyperphosphatemia, such as bone disorders and cardiovascular issues.

Description:

Sevelamer Carbonate 400 mg is a non-absorbed phosphate binder used in the treatment of hyperphosphatemia (high phosphate levels) in patients with chronic kidney disease (CKD) undergoing dialysis. It works in the gastrointestinal tract to bind dietary phosphate, thereby reducing its absorption and lowering serum phosphate levels. Unlike calcium-based binders, Sevelamer does not increase calcium levels, reducing the risk of vascular calcification.

Tags:

CKD Care Phosphate Binder Dialysis Support Nephrology Kidney Health Prescription Drugs Tablets
  • Controls high phosphate levels in dialysis patients
  • Reduces risk of cardiovascular and bone complications
  • Non-calcium binder – does not raise calcium levels
  • Minimal absorption – acts locally in the gut
  • Safer for long-term phosphate control in CKD

Usage Information

Dosage

Usual Dose: As directed by your doctor General Practice: Taken 3 times a day with meals Swallow whole with water Do not chew or crush tablets Follow phosphate-restricted diet for best results

Side Effects

Nausea or vomiting Constipation Flatulence or gas Stomach pain Rarely: bowel obstruction Contact your doctor if symptoms persist or worsen.

Contraindications

Known hypersensitivity to Sevelamer Bowel obstruction or intestinal motility issues Severe constipation or history of gastrointestinal perforation Use in non-dialysis patients without medical advice